NetraMark Holdings Inc. (the "Company" or "NetraMark") (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0) a premier artificial intelligence (AI) company that is transforming clinical trials with AI powered ...

The global clinical trials market is anticipated to grow at a CAGR of 6-7% from 2024 to 2029. This growth is driven by the ...

Research reveals how specific sleep stages protect brain vulnerable to Alzheimer's, offering hope through simple lifestyle ...

We came across a bullish thesis on Medpace Holdings, Inc. (MEDP) on Substack by Tired Salary Bear. In this article, we will ...

Spending lower proportions of time in two deep sleep stages — including REM sleep — may be linked to volume changes in ...

First VISTA Inhibitor Drug Approval By 2028 Says Kuick Research In New Research Publication. Delhi, April 02, 2025 (GLOBE NEWSWIRE) -- Global VISTA Inhibitor Clini ...

Advanced PG Diploma in Clinical research, Pharmacovigilance, Medical Coding | Certified in Clinical SAS | Aspiring Data Management Professional | Ex-Optum | Sharing Knowledge about CR | Founder of ...

None of the cell and gene therapies that reached the final regulatory submission stage were rejected by the FDA.

What if a single protein could control hair growth? Scientists reveal how MCL-1 protects hair follicles and may unlock new ...

AQILION AB (publ) presents results from a study conducted by the Company together with Professor Evan Dellon after the research group's abstract was approved at this year's Digestive Disease Week, May ...

PHILADELPHIA, PA — Cabaletta Bio, Inc. (Nasdaq: CABA) has announced its financial results for the fourth quarter and full ...

The review article titled"Current insights and future directions in Peyronie's disease management: A narrative review", was ...